Anti-Vaccinia A33 glycoprotein (A2C7)

Anti-Vaccinia A33 glycoprotein [A2C7], Recombinant, IgG2b kappa, Mouse
Artikelnummer
ABAAb00766-3.0
Verpackungseinheit
200 μg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: A2C7

Antigen Long Description: This antibody was prepared by intranasally infecting BALB/c mice with an attenuated vaccinia virus (VACV) mutant, followed by a boost with an intravenous injection of UV-inactivated WT VACV.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Specificity Statement: This antibody is specific for the VACV antigen A33, a viral glycoprotein associated with the outer membrane of extracellular enveloped viruses. A33 is known to elicit protective antibody responses.

Application Notes (Clone): The specificity of this antibody for VACV has been confirmed by IF assays (Meng, 2011). This antibody exhibited strong complement-mediated neutralization of the extracellular enveloped form of vaccinia virus in the presence of complement, and was able to protect mice against weight loss and death following an in vivo VACV challenge (Matho, 2015).
Mehr Informationen
Artikelnummer ABAAb00766-3.0
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab00766-3.0
Verpackungseinheit 200 μg
Mengeneinheit STK
Reaktivität Virus
Klonalität Recombinant
Methode Immunofluorescence, Neutralization
Isotyp IgG2b kappa
Wirt Mouse
Produktinformation (PDF) Download
MSDS (PDF) Download